Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review
- Jafari M. , et al.
2. A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran
- Jafari M. , et al.
3. Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study
- Jafari M. , et al.
4. Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C
- Goudarzi Z. , et al.
5. A cost-utility analysis of different antiviral medicine regimens in patients with chronic hepatitis c virus genotype 1 infection
- Alavian S.M. , et al.
6. Next steps toward eradication of hepatitis C in the era of direct acting antivirals
- Hesamizadeh K. , et al.
7. New use of an old drug: Chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial)
- Peymani P. , et al.
8. Occult HCV infection: The current state of knowledge
- Rezaee-Zavareh M. , et al.